Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Classification of Biomarkers
- Examples of Biomarkers
- Susceptibility/Risk Biomarkers
- Diagnostic Biomarkers
- Monitoring Biomarkers
- Prognostic Biomarkers
- Predictive Biomarkers
- Pharmacodynamic (Response) Biomarkers
- Safety Biomarkers
- Surrogate Biomarkers/Endpoints
- Discovery, Verification and Validation
- Biomarker Qualification
- Applications of Biomarkers
- Diagnostics, Therapeutics and Disease Monitoring
- Drug Discovery and Development
- Clinical Trials
Chapter 3 Market Dynamics
- Overview
- Market Drivers
- Rising Incidence of Diseases
- Advances in Omics and Imaging Technologies
- Market Restraints
- High Development Costs
- Requirement for Skilled Labor
- Market Opportunities
- Emerging Markets
- Personalized Medicine
Chapter 4 Emerging Technologies and Developments
- Overview
- Emerging Technologies
- Genomics
- Proteomics
- Metabolomics
- Imaging
- Bioinformatics
- Clinical Trials
- Clinical Trial Analysis, by Therapeutic Area
- Clinical Trial Analysis, by Study Status
- Clinical Trial Analysis, by Study Type
- Patent Analysis
Chapter 5 Market Segmentation Analysis
- Market Trends
- Segmentation Breakdown
- Biomarkers: Global Markets
- Market Analysis by Product Type
- Consumables
- Instruments
- Services
- Software
- Market Analysis by Technology
- Proteomics
- Genomics
- Imaging
- Bioinformatics
- Metabolomics
- Market Analysis by Therapeutic Area
- Cancer
- Cardiovascular and Metabolic Diseases
- Neurodegenerative Diseases
- Infectious Diseases
- Autoimmune Diseases
- Other Diseases
- Market Analysis by End User
- Hospitals and Diagnostic Labs
- Academic and Research Institutes
- Pharmaceutical and Biotech Companies
- Contract Research Organizations
- Geographic Breakdown
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Ranking of Companies in the Biomarker Industry
Chapter 7 Sustainability in Biomarkers Technologies and Global Markets: An ESG Perspective
- Sustainability in the Biomarker Market
- ESG Risks and Ratings: Understanding the Data
- BCC Research Viewpoint
List of Tables
Summary Table A: Global Market for Biomarkers, by Product Type, Through 2029
Summary Table B: Global Market for Biomarkers, by Region, Through 2029
Table 1: Categories of Biomarkers
Table 2: Examples of Biomarkers
Table 3: Clinical Trials in Biomarkers, by Therapeutic Area, 2021-2024*
Table 4: Clinical Trials in Biomarkers, by Study Status, 2021-2024*
Table 5: Clinical Trials in Biomarkers, by Type of Study, 2021-2024*
Table 6: Patents Issued for Biomarkers, 2021-2024*
Table 7: Patents Issued for Biomarkers, by Applicant, 2021-2024*
Table 8: Global Market for Biomarkers, Through 2029
Table 9: Global Market for Biomarkers, by Product Type, Through 2029
Table 10: Global Market for Biomarkers, by Technology, Through 2029
Table 11: Global Market for Biomarkers, by Therapeutic Area, Through 2029
Table 12: Global Market for Biomarkers, by End User, Through 2029
Table 13: Global Market for Biomarkers, by Region, Through 2029
Table 14: North American Market for Biomarkers, by Country, Through 2029
Table 15: European Market for Biomarkers, by Country, Through 2029
Table 16: Asia-Pacific Market for Biomarkers, by Country, Through 2029
Table 17: RoW Market for Biomarkers, by Sub-region, Through 2029
Table 18: Market Rankings of Leading Companies in the Biomarker Industry, 2023
Table 19: ESG Rankings for Major Biomarker Companies, 2024*
Table 20: Information Sources in This Report
Table 21: Abbreviations Used in This Report
Table 22: Abbott: Company Snapshot
Table 23: Abbott: Financial Performance, FY 2022 and 2023
Table 24: Abbott: Product Portfolio
Table 25: Abbott: News/Key Developments, 2023-2024
Table 26: Agilent Technologies Inc.: Company Snapshot
Table 27: Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 28: Agilent Technologies Inc.: Product Portfolio
Table 29: Agilent Technologies Inc.: News/Key Developments, 2023-2024
Table 30: Bayer AG: Company Snapshot
Table 31: Bayer AG: Financial Performance, FY 2022 and 2023
Table 32: Bayer AG: Product Portfolio
Table 33: Bayer AG: News/Key Developments, 2022-2024
Table 34: BD: Company Snapshot
Table 35: BD: Financial Performance, FY 2022 and 2023
Table 36: BD: Product Portfolio
Table 37: BD: News/Key Developments, 2024
Table 38: Bio-Rad Laboratories Inc.: Company Snapshot
Table 39: Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 40: Bio-Rad Laboratories Inc.: Product Portfolio
Table 41: Bio-Rad Laboratories Inc.: News/Key Developments, 2024
Table 42: Bruker: Company Snapshot
Table 43: Bruker: Financial Performance, FY 2022 and 2023
Table 44: Bruker: Product Portfolio
Table 45: Bruker: News/Key Developments, 2023
Table 46: Danaher Corp.: Company Snapshot
Table 47: Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 48: Danaher Corp.: Product Portfolio
Table 49: Danaher Corp.: News/Key Developments, 2022-2024
Table 50: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 51: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 52: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 53: F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023
Table 54: Fujifilm Holdings Corp.: Company Snapshot
Table 55: Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023
Table 56: Fujifilm Holdings Corp.: Product Portfolio
Table 57: GE Healthcare: Company Snapshot
Table 58: GE Healthcare: Financial Performance, FY 2022 and 2023
Table 59: GE Healthcare: Product Portfolio
Table 60: GE Healthcare: News/Key Developments, 2024
Table 61: Illumina Inc.: Company Snapshot
Table 62: Illumina: Financial Performance, FY 2022 and 2023
Table 63: Illumina: Product Portfolio
Table 64: Illumina Inc.: News/Key Developments, 2024
Table 65: JEOL Ltd.: Company Snapshot
Table 66: JEOL Ltd.: Financial Performance, FY 2022 and 2023
Table 67: JEOL Ltd.: Product Portfolio
Table 68: JEOL Ltd.: News/Key Developments, 2023
Table 69: Koninklijke Philips N.V.: Company Snapshot
Table 70: Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023
Table 71: Koninklijke Philips N.V.: Product Portfolio
Table 72: Koninklijke Philips N.V.: News/Key Developments, 2022 and 2023
Table 73: Promega Corp.: Company Snapshot
Table 74: Promega Corp.: Product Portfolio
Table 75: Promega Corp.: News/Key Developments, 2023 and 2024
Table 76: Qiagen: Company Snapshot
Table 77: Qiagen: Financial Performance, FY 2022 and 2023
Table 78: Qiagen: Product Portfolio
Table 79: Qiagen: News/Key Developments, 2023
Table 80: Revvity: Company Snapshot
Table 81: Revvity: Financial Performance, FY 2022 and 2023
Table 82: Revvity: Product Portfolio
Table 83: Revvity: News/Key Developments, 2022 and 2023
Table 84: Shimadzu Corp.: Company Snapshot
Table 85: Shimadzu Corp.: Financial Performance, FY 2022 and 2023
Table 86: Shimadzu Corp.: Product Portfolio
Table 87: Shimadzu Corp.: News/Key Developments, 2023
Table 88: Siemens Healthineers AG: Company Snapshot
Table 89: Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
Table 90: Siemens Healthineers AG: Product Portfolio
Table 91: Siemens Healthineers AG: News/Key Developments, 2024
Table 92: Thermo Fisher Scientific Inc.: Company Snapshot
Table 93: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 94: Thermo Fisher Scientific Inc.: Product Portfolio
Table 95: Thermo Fisher Scientific Inc.: News/Key Developments, 2023 and 2024
List of Figures
Summary Figure A: Global Market for Biomarkers, by Product Type, 2021-2029
Summary Figure B: Global Market for Biomarkers, by Product Type, 2021-2029
Figure 1: Snapshot of the Market Dynamics of Biomarkers
Figure 2: Share of Global Market for Biomarkers, by Product Type, 2023
Figure 3: Share of Global Market for Biomarkers, by Technology, 2023
Figure 4: Share of Global Market for Biomarkers, by Therapeutic Area, 2023
Figure 5: Share of Global Market for Biomarkers, by End User, 2023
Figure 6: Share of Global Market for Biomarkers, by Region, 2023
Figure 7: Share of North American Market for Biomarkers, by Country, 2023
Figure 8: Share of European Market for Biomarkers, by Country, 2023
Figure 9: Share of Asia-Pacific Market for Biomarkers, by Country, 2023
Figure 10: Share of RoW Market for Biomarkers, by Sub-region, 2023
Figure 11: Abbott: Revenue Share, by Business Unit, FY 2023
Figure 12: Abbott: Revenue Share, by Country/Region, FY 2023
Figure 13: Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 14: Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 15: Bayer AG: Revenue Share, by Business Unit, FY 2023
Figure 16: Bayer AG: Revenue Share, by Country/Region, FY 2023
Figure 17: BD: Revenue Share, by Business Unit, FY 2023
Figure 18: BD: Revenue Share, by Country/Region, FY 2023
Figure 19: Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 20: Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 21: Bruker: Revenue Share, by Business Unit, FY 2023
Figure 22: Bruker: Revenue Share, by Country/Region, FY 2023
Figure 23: Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 24: Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 25: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 26: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 27: Fujifilm Holdings Corp.: Revenue Share, by Business Unit, FY 2023
Figure 28: Fujifilm Holdings Corp.: Revenue Share, by Country/Region, FY 2023
Figure 29: GE Healthcare: Revenue Share, by Business Unit, FY 2023
Figure 30: GE Healthcare: Revenue Share, by Country/Region, FY 2023
Figure 31: Illumina: Revenue Share, by Business Unit, FY 2023
Figure 32: Illumina: Revenue Share, by Country/Region, FY 2023
Figure 33: JEOL Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 34: JEOL Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 35: Koninklijke Philips N.V.: Revenue Share, by Business Unit, FY 2023
Figure 36: Koninklijke Philips N.V.: Revenue Share, by Country/Region, FY 2023
Figure 37: QIAGEN: Revenue Share, by Business Unit, FY 2023
Figure 38: Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 39: Revvity: Revenue Share, by Business Unit, FY 2023
Figure 40: Revvity: Revenue Share, by Country/Region, FY 2023
Figure 41: Shimadzu Corp.: Revenue Share, by Business Unit, FY 2023
Figure 42: Shimadzu Corp.: Revenue Share, by Country/Region, FY 2023
Figure 43: Siemens Healthineers AG: Revenue Share, by Business Unit, FY 2023
Figure 44: Siemens Healthineers AG: Revenue Share, by Country/Region, FY 2023
Figure 45: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2023
Figure 46: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023
